This study investigated the protective effects of carvedilol alone and coadministered with prednisolone and diltiazem on doxorubicin (DOX) and 5-fluorouracil (5-FU)-induced toxicity. Each of 2 pools of 70 female rats were randomly allotted into 10 groups of 7 animals each and treated as follows: Group 1: normal saline (10 mL/kg); Carvedilol administered alone and coadministered with diltiazem and prednisolone reduced the effect of DOX/5-FU-induced hepatic and renal toxicities due to enhanced in vivo antioxidant activity. The protective effect was more prominent in
The use of this drug is limited by toxic effects on body organs, causing cardiac, pulmonary, hepatic, renal, hematological, and testicular toxicities. 2 
5-Fluorouracil (5-FU), an
antimetabolite, has played an important role in the management of colon and breast cancers, and cancers involving the head and neck. 3 Despite the many advantages, its clinical application has been greatly limited due to drug resistance and organ toxicity.
The incidence of drug-induced hepatotoxicity and nephrotoxicity has been increasing with the ever-increasing number of drugs and with easy availability of over the counter medications, with hepatotoxicity being important cause of morbidity and mortality and the most common reason for new drugs withdrawal. 4 Most drug-induced nephrotoxicities exert toxic effects by one or more common pathological mechanisms, including altered intraglomerular hemodynamics, tubular cell toxicity, inflammation, crystal nephropathy, rhabdomyolysis, and thrombotic microangiopathy. 5 Redressive measures/interventions are needed to reduce vital organ toxicities posed by doxorubicin, 5-FU, and other clinically useful chemotherapeutic agents that are normally used at relatively high doses and for an appreciable period of time. Developing new drugs or discovering the other clinical potentials of existing drugs will help in this regard.
Prednisolone (phospholipase A 2 inhibitor) has been demonstrated to have anti-inflammatory property, and ameliorate symptoms and improve biochemical and histologic abnormalities in many types of liver diseases, including autoimmune hepatitis, cirrhosis patients with septic shock, and liver transplantation. [6] [7] [8] [9] Calcium ions (Ca
2+
) are major regulators of vital cellular functions and interference with Ca 2+ homeostasis contributes to cell injury and death in a number of pathological conditions. 10, 11 Diltiazem is a calcium channel blocker and calcium antagonism/blockade has been exploited in the management of cell injury. 12 Carvedilol is a third-generation nonselective beta-blocker with vasodilatory property due to alpha 1 blockade. 13 It has also been reported to possess antioxidant property in terms of free radical scavenging and inhibition of lipid peroxidation. 14, 15 This study aimed to determine the protective effect of carvedilol alone and coadministered with diltiazem and prednisolone against doxorubicin and 5-FU-induced liver and kidney toxicities.
| MATERIALS AND METHODS

| Drugs and chemicals
The following drugs and chemicals were used in this study: Doxorubicin (Get Well Pharmaceuticals, Gurgaon, India), 5-Fluorouracil (Celon Laboratories Ltd., Gajularamaram, India), Carvedilol (Roche, Mannheim, Germany), Prednisolone (Hovid Berhad, Malaysia), Diltiazem (Sanofi-Aventis S.p.A., Milan, Italy), and Formalin (Unique Pharmaceuticals, Sango-Ota, Nigeria).
| Animals
Seventy female Wistar rats weighing 150-200 g were obtained from the Laboratory Animal Centre of the College of Medicine, University of Lagos, Lagos, Nigeria. The animals were housed at 25°C with 12 hours light/dark cycle, allowed to acclimatize for 14 days before commencement of the experiment, and had free access to standard feed (Livestock Feeds Plc., Lagos, Nigeria) and water. The experimental protocol was in conformity with the guidelines of the United States National Academy of Sciences Guide for the Care and Use of Laboratory Animals. 16 
| Treatment
Seventy female rats were randomly allotted into 10 groups of 7 animals each and treated as follows:
Group 1 (Control): Normal saline (10 mL/kg).
Group 2: Normal saline (10 mL/kg) and doxorubicin alone (40 mg/kg). 18 A day after administration stopped (day 15), blood samples were collected into plain sample bottles for analysis.
Rats were sacrificed humanely under inhaled diethyl ether anesthesia, laparatomized and the liver and kidneys were harvested for antioxidant indices and histopathological assessments.
| Biochemical analysis
Blood sample was collected from each rat at the end of the drug administration period, via retro-orbital artery bleeding under anesthesia, into plain sample bottles for biochemical analysis. Blood collected into plain bottles was allowed to clot at room temperature and centrifuged to obtain the serum. The sera were analyzed using Randox diagnostic kits (Randox Laboratories Ltd., London, England)
to assess aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) activities, and the determination of concentrations of serum total protein, albumin, urea, creatinine, high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and triglycerides (TG), according to established protocols. 19 
| Antioxidant indices analysis
Malondialdehyde (MDA) was assayed using the method described by Janero and Burghardt. 20 Assay of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), and reduced glutathione (GSH) was performed according to established procedures. 
| Statistical analysis
Data were analyzed by one-way ANOVA followed by Tukey's multiple comparison test using GraphPad Prism 5 (GraphPad Software Inc., CA). Results were expressed as mean AE SEM and values were considered significant at P < .05.
3 | RESULTS
| Biochemical parameters (doxorubicin model)
Administration of doxorubicin caused a significant (P < .05) increase in the levels of AST, ALT, and ALP, as well as a significant (P < .05) decrease in albumin relative to the animals administered normal saline alone. In the presence of doxorubicin, administration of carvedilol (all doses) significantly (P < .05) decreased AST, ALT, and ALP compared with rats administered doxorubicin alone. Coadministration of diltiazem and carvedilol (in the presence of doxorubicin) caused a significant (P < .05) decrease in ALT and AST enzymes compared with rats administered doxorubicin alone. In the presence of doxorubicin, administration of prednisolone and carvedilol resulted in a significant (P < .05) decrease in only ALT enzyme (Table 1) .
A significant (P < .05) increase in creatinine level in animals administered doxorubicin relative to those that received normal saline was observed ( Table 2 ). Administration of carvedilol (all doses), in the presence of doxorubicin, significantly (P < .05) decreased creatinine level compared with animals administered doxorubicin alone.
In the presence of doxorubicin, coadministration of diltiazem and carvedilol, as well as prednisolone and carvedilol also significantly (P < .05) decreased creatinine level relative to rats administered doxorubicin alone (Table 2 ).
| Antioxidant indices (doxorubicin model)
In respect of the liver, Table 3 shows significant (P < .05) decreases in the levels of CAT, SOD, GSH, and GPx, and significant (P < .05) increase in MDA level in rats administered doxorubicin alone compared with the animals administered normal saline (control). Carvedilol (0.43 mg/kg) significantly (P < .05) reduced the level of MDA relative to the doxorubicin alone administered rats. In the presence of doxorubicin, coadministration of carvedilol and diltiazem significantly (P < .05) increased the levels of SOD and CAT, with a significant (P < .05) decrease in MDA level relative to the toxicant group.
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In respect of the kidneys, results in Table 4 shows significant (P < .05) decreases in the levels of CAT, SOD, and GPx, and a significant (P < .05) increase in MDA level following administration of doxorubicin compared with animals administered normal saline (control). Administration of carvedilol in the presence of doxorubicin caused significant (P < .05) increases in SOD, CAT, and GPx levels and a significant (P < .05) decrease in MDA relative to animals administered doxorubicin alone. In the presence of doxorubicin, coadministration of carvedilol and diltiazem significantly (P < .05)
increased the levels of SOD, CAT, and GPx, with a significant (P < .05) decrease in MDA level relative to the toxicant group. Carvedilol combined with prednisolone (in the presence of the toxicant) caused significant (P < .05) increases in the levels of CAT, SOD, and
GPx, but insignificant (P > .05) decrease in MDA level compared with the rats administered doxorubicin.
T A B L E 1 Effect of carvedilol alone and coadministered with prednisolone and diltiazem (in the presence of doxorubicin) on liver enzymes and albumin 
| Biochemical parameters (5-FU model)
Results showed that administration of 5-FU significantly (P < 0.05)
increased AST level compared with normal saline (control) ( Table 5 ).
Administration of carvedilol alone and coadministered with diltiazem or prednisolone significantly (P < .05) decreased AST level relative to rats that received 5-FU alone.
As shown in Table 6 , a significant (P < .05) increase in creatinine level was observed in rats administered 5-FU compared with the control group. In the presence of 5-FU, administration of carvedilol alone (all doses) and coadministered with diltiazem significantly (P < .05) reduced the creatinine level compared with the rats that received 5-FU only.
| Antioxidant indices (5-FU model)
In respect of the liver, significant (P < .05) decreases in CAT, SOD, GSH, and GPx levels and a significant (P < .05) increase in MDA T A B L E 3 Effect of carvedilol alone and coadministered with prednisolone and diltiazem (in the presence of doxorubicin) on antioxidant indices in the liver level were observed in rats administered 5-FU relative to the normal saline (control) group (Table 7) . Carvedilol (0.075 mg/kg) coadministered with 5-FU produced a significant (P < .05) increase in the level of CAT and significant (P < .05) decrease in MDA level compared with rats administered 5-FU alone. Coadministration of carvedilol and prednisolone (in the presence of 5-FU) caused significant (P < .05) increases in the levels of CAT, SOD, and GPx, and a significant (P < .05) decrease in MDA level compared with rats that received 5-FU alone.
In respect of the kidney, 5-FU administration significantly (P < .05) decreased GSH and increased MDA levels compared with rats administered normal saline (control) ( Table 8) . Carvedilol (0.075 mg/kg) in the presence of 5-FU increased CAT, SOD, and GSH levels significantly (P < .05). In the presence of 5-FU, a higher dose of carvedilol (0.15 mg/kg) caused significant (P < .05) increases in the levels of CAT and GSH, and a significant (P < .05) decrease in MDA level compared with rats that received 5-FU only. Coadministration of carvedilol and diltiazem significantly (P < .05) increased the levels of 
| DISCUSSION
The protective role of carvedilol administered alone and with either prednisolone or diltiazem in doxorubicin-and 5-fluorouracil-induced hepato-and nephrotoxicity in female Wistar rats was examined in this study. Liver function tests are a useful diagnostic tool; thus, an elevation in AST and the liver-specific ALT indicates leakage from injured tissues caused by hepatocellular necrosis, 23 while increase in ALP level is due to overproduction and release in blood following hepatobiliary injury and cholestasis. 24 In this study, significant Although the presence of diltiazem did not add any advantage as against using carvedilol alone in this study, the ability of diltiazem to protect or reduce injury caused by toxicants had earlier been reported by Bojani c et al. 28 This study revealed that doxorubicin and 5-FU, known nephrotoxicants, 17, 29 caused a deterioration of renal function as observed by a significant increase in creatinine, with a nonsignificant increase in urea, compared with the control group. Urea and creatinine taken together gives very accurate estimation of kidney function;
however, creatinine is a more accurate predictor of kidney damage or injury than urea, though both the liver and kidney must be functioning properly for the body to maintain a normal level of urea in the blood. Oxidative stress occurs when there is an imbalance between pro-oxidants and antioxidants in favor of the former, which is very harmful to cells. 33 Free radicals that are produced due to oxidative stress engage and overwhelm antioxidant enzymes, resulting in the depletion of the antioxidant defenses and induction of lipid peroxidation evident in elevation of MDA level. 34, 35 This contributes to the initiation and progression of hepatic damage in a variety of liver disorders. 36 In order to maintain the stability in living organisms, it is necessary to maintain balance between the oxidative and antioxidant defense. in doxorubicin-induced production of reactive oxygen species. 44 The nephroprotective effect of carvedilol has been reported in hypertensive-stroke prone rats, 31 owing to its additional antioxidant activity. 45 
